12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      HSP90 IN CANCER: TRANSCRIPTIONAL ROLES IN THE NUCLEUS

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hsp90 plays a key role in fostering metabolic pathways essential in tumorigenesis through its functions as a molecular chaperone. Multiple oncogenic factors in the membrane and cytoplasm are thus protected from degradation and destruction. Here we have considered Hsp90’s role in transcription in the nucleus. Hsp90 functions both in regulating the activity of sequence specific transcription factors such as nuclear receptors and HSF1, as well as impacting more globally acting factors that act on chromatin and RNA polymerase II. Hsp90 influences transcription by modulating histone modification mediated by its clients SMYD3 and trithorax / MLL, as well as by regulating the processivity of RNA polymerase II through negative elongation factor (NELF). It is not currently clear how the transcriptional role of Hsp90 may be influenced by the cancer milieu although recently discovered posttranslational modification of the chaperone may be involved. Dysregulation of Hsp90 may thus influence malignant processes both by modulating the function of specific transcription factors and effects on more globally acting general components of the transcriptional machinery.

          Related collections

          Author and article information

          Journal
          0370416
          262
          Adv Cancer Res
          Adv. Cancer Res.
          Advances in cancer research
          0065-230X
          2162-5557
          4 October 2019
          12 October 2015
          2016
          13 October 2019
          : 129
          : 89-106
          Affiliations
          [1 ]Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA02215,
          [2 ]Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892.
          Author notes
          Correspondence should be addressed to Stuart K Calderwood, Center for Life Sciences, 3 Blackfan Circle, Boston MA02115, scalderw@ 123456bidmc.harvard.edu .
          Article
          PMC6790218 PMC6790218 6790218 nihpa1050954
          10.1016/bs.acr.2015.08.002
          6790218
          26916002
          cf09fd57-73c5-4386-9b9c-770431e20be3
          History
          Categories
          Article

          Hsp90,trithorax,RNA polymerase II,modification,posttranslational,cancer transcription

          Comments

          Comment on this article